IS5829A - Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni - Google Patents

Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni

Info

Publication number
IS5829A
IS5829A IS5829A IS5829A IS5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A
Authority
IS
Iceland
Prior art keywords
iratatoxin
peptide fragments
cholera toxin
vaccine adjuvants
vaccine
Prior art date
Application number
IS5829A
Other languages
English (en)
Inventor
Raymond Hirst Timothy
Andrew Williams Neil
Original Assignee
University Of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Bristol filed Critical University Of Bristol
Publication of IS5829A publication Critical patent/IS5829A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IS5829A 1998-09-07 2001-01-26 Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni IS5829A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9819484.8A GB9819484D0 (en) 1998-09-07 1998-09-07 Therapeutic agents
PCT/GB1999/002970 WO2000014114A1 (en) 1998-09-07 1999-09-07 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants

Publications (1)

Publication Number Publication Date
IS5829A true IS5829A (is) 2001-03-07

Family

ID=10838466

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5829A IS5829A (is) 1998-09-07 2001-01-26 Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni

Country Status (19)

Country Link
EP (1) EP1109828A1 (is)
JP (1) JP2002524469A (is)
KR (1) KR20010044842A (is)
CN (1) CN1317013A (is)
AU (1) AU772015B2 (is)
BR (1) BR9913501A (is)
CA (1) CA2338384A1 (is)
CZ (1) CZ2001839A3 (is)
EA (1) EA200100314A1 (is)
GB (2) GB9819484D0 (is)
HU (1) HUP0104090A2 (is)
IL (1) IL141695A0 (is)
IS (1) IS5829A (is)
MX (1) MXPA01002387A (is)
NO (1) NO20011075L (is)
NZ (1) NZ509631A (is)
PL (1) PL346549A1 (is)
WO (1) WO2000014114A1 (is)
ZA (1) ZA200100758B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010036917A1 (en) 1995-07-05 2001-11-01 Williams Neil Andrew Therapeutic agents
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
GB0115382D0 (en) 2001-06-22 2001-08-15 Univ Bristol Mutant
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
CN104402974B (zh) * 2014-12-10 2017-11-14 重庆医科大学 一种具有粘膜免疫佐剂活性的多肽及其在制备粘膜免疫佐剂中的用途
WO2024121125A1 (en) * 2022-12-06 2024-06-13 Bactolife A/S Single-domain antibodies to reduce the risk of cholera infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527445A1 (fr) * 1982-05-26 1983-12-02 Centre Nat Rech Scient Medicaments contenant au moins une sequence de la sous-unite b1 de la toxine cholerique
IL69558A (en) * 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
ZA839512B (en) * 1983-12-12 1984-08-29 Scripps Clinic Res Synthetic heat-stable enterotoxin polypeptide of escherichia coli and multimers thereof
FR2636842B1 (fr) * 1988-09-27 1994-06-10 Liege Universite Etat Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion
CA2180726A1 (en) * 1994-01-27 1995-08-03 Evgeni Veniaminovic Sokurenko Receptor specific bacterial adhesins and their use
IL109519A (en) * 1994-05-03 1999-03-12 Yeda Res & Dev Vaccines for oral immunization against infecting agents
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant

Also Published As

Publication number Publication date
EP1109828A1 (en) 2001-06-27
ZA200100758B (en) 2001-07-16
WO2000014114A1 (en) 2000-03-16
CZ2001839A3 (cs) 2001-08-15
GB0107375D0 (en) 2001-05-16
EA200100314A1 (ru) 2001-10-22
AU772015B2 (en) 2004-04-08
IL141695A0 (en) 2002-03-10
NO20011075L (no) 2001-05-07
MXPA01002387A (es) 2002-05-08
AU5751699A (en) 2000-03-27
CA2338384A1 (en) 2000-03-16
NZ509631A (en) 2003-11-28
GB2357507A (en) 2001-06-27
JP2002524469A (ja) 2002-08-06
HUP0104090A2 (hu) 2002-01-28
KR20010044842A (ko) 2001-06-05
PL346549A1 (en) 2002-02-11
GB9819484D0 (en) 1998-10-28
NO20011075D0 (no) 2001-03-02
BR9913501A (pt) 2001-06-05
CN1317013A (zh) 2001-10-10

Similar Documents

Publication Publication Date Title
NL300311I2 (nl) Adjuvanssytemen en vaccins
NO20004758D0 (no) Vaksinesammensetning
DE69933200D1 (de) Kombinierte impfstoffzusammensetzungen
EP1089751A4 (en) Adjuvant therapy
NO20003303L (no) Vaksine
IS4661A (is) Tæki í innúðara
NO20006191D0 (no) Vaksine
AU2001277961A1 (en) Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
DE69730092D1 (de) Photovernetzbare Siliconzusammensetzungen
HUP0300099A3 (en) Vaccine for the treatment of artherosclerosis
CY2006004I1 (el) Μεθοδος διαχωρισμου παραλλαγων ροταϊου και ζωντανο εξασθενημενο εμβολιο ροταϊου
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
DZ2283A1 (fr) Composition de vaccin.
EP1423141A4 (en) VACCINE
DK1109574T3 (da) Vaccine mod seksuelt overförte sygdomme
FI20070041L (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
IS5829A (is) Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni
AUPQ712000A0 (en) Antigenic peptide fragments of VapA protein, and uses thereof
KR100694919B1 (ko) gp41 단편의 아세틸화
NO20005599L (no) Vaksine
EE200000694A (et) Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
AU2001267613A1 (en) Adjuvant composition comprising FHA protein or fragment of FHA protein in free form
HK1036807A (en) Peptide fragments os cholera toxin b or enterotoxin b as vaccine adjuvants
DK1117421T3 (da) Hidtil ukendte fremgangsmåder til terapuetisk vaccination